BioLife Solutions Reports Third Quarter 2022 Financial Results

Go back to BioLife Solutions Reports Third Quarter 2022 Financial Results

BioLife Solutions (BLFS) Misses Q3 EPS by 7c; Offers FY22 Revenue Guidance

November 9, 2022 4:22 PM EST

BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.23), $0.07 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $40.7 million versus the consensus estimate of $42.02 million.

GUIDANCE:

BioLife Solutions sees FY2022 revenue of $160-164 million, versus the consensus of... More